<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00920894</url>
  </required_header>
  <id_info>
    <org_study_id>Kainuu PlantStanol Ester Study</org_study_id>
    <nct_id>NCT00920894</nct_id>
  </id_info>
  <brief_title>Effect of Plant Stanol Esters on Blood Lipids</brief_title>
  <official_title>The Effect of Plant Stanol Esters on Serum Total and Lipoproteins Lipids, Non-cholesterol Sterols and Apolipoproteins in Subjects With Elevated Blood Lipid Concentration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Life Sciences Ltd.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Life Sciences Ltd.</source>
  <brief_summary>
    <textblock>
      This study aims to measure the effect of plant stanol esters on serum total and lipoproteins
      lipids, non-cholesterol sterols and apolipoproteins in subjects with elevated fasting blood
      lipid concentrations
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The link between high serum low-density lipoprotein (LDL) cholesterol and cardiovascular
      disease has long been recognized. Dietary plant stanol esters have been shown to effectively
      reduce serum levels of total and LDL cholesterol. Plant stanols decrease the absorption of
      both biliary and dietary cholesterol from the small intestine and thereby reduce serum LDL
      cholesterol levels.

      This study aims to verify the effect of plant stanol esters on blood lipids. Subjects with
      elevated fasting blood lipid concentrations will be randomized to study groups. The groups
      consume yoghurt type minidrink containing plant stanol ester (2 g plant stanols per day) or
      similar minidrink without plant stanol esters. After 10 weeks study period serum total and
      lipoproteins lipids, non-cholesterol sterols and apolipoproteins will by analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma lipids</measure>
    <time_frame>10 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma lipoprotein lipids non-cholesterol sterols</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Elevated Blood Lipids</condition>
  <arm_group>
    <arm_group_label>yoghurt type minidrink containing plant stanol ester</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>yoghurt type minidrink without plant stanol ester</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>plant stanol ester</intervention_name>
    <description>the effect of plant stanol esters on plasma lipids</description>
    <arm_group_label>yoghurt type minidrink containing plant stanol ester</arm_group_label>
    <arm_group_label>yoghurt type minidrink without plant stanol ester</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elevated blood lipids

          -  Body Mass Index &lt; 35 kg/m2

          -  Stable body weight

        Exclusion Criteria:

          -  Receiving medications or supplements other than stable statin therapy known to affect
             lipid metabolism

          -  Severe obesity

          -  Hyperglycemia

          -  Severe diseases (inc. diabetes, unstable CVD, malignant disease, inflammatory disease,
             gastrointestinal disease)

          -  Hepatic, kidney or thyroid disease or disorder

          -  Pregnancy or breast feeding

          -  Severe intolerance or allergy to any ingredient of test product
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Life Sciences Ltd</name>
      <address>
        <city>Vuokatti</city>
        <zip>88610</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2009</study_first_submitted>
  <study_first_submitted_qc>June 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2009</study_first_posted>
  <last_update_submitted>November 4, 2009</last_update_submitted>
  <last_update_submitted_qc>November 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>PÃ¤ivi Cheney, MD</name_title>
    <organization>Clinical Life Sciences Ltd</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

